IL-5 antagonism reverses priming and activation of eosinophils in severe eosinophilic asthma
Author:
Funder
NIHR Oxford Biomedical Research Centre
National Institute for Health and Care Research
Wellcome Trust
Publisher
Elsevier BV
Reference57 articles.
1. What is an “eosinophilic phenotype” of asthma?;Nair;J. Allergy Clin. Immunol.,2013
2. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial;Green;Lancet,2002
3. Tissue remodeling and angiogenesis in asthma: the role of the eosinophil;Nissim Ben Efraim;Ther. Adv. Respir. Dis.,2008
4. Increased chemokinetic and chemotactic responses of eosinophils in asthmatic patients;Griffin;Allergy,1991
5. Comparative efficacy of mepolizumab, Benralizumab, and dupilumab in eosinophilic asthma: a Bayesian network meta-analysis;Akenroye;J. Allergy Clin. Immunol.,2022
Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Navigating the Terrain: Type 2 Cytokines and Biologic intervention in Severe Eosinophilic Asthma;Eosinophils and Their Role in Human Health and Disease [Working Title];2024-08-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3